EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Luteolin exerts anti‐tumour immunity in hepatocellular carcinoma by accelerating CD8 + T lymphocyte infiltration

Shijiao Cai iD, Yidan Gou, Yanyan Chen, Xiaoran Hou, Jing Zhang, Chongwen Bi, Peng Gu, Miao Yang, Hanxu Zhang, Weilong Zhong iD, Hengjie Yuan

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18535 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Shijiao Cai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Luteolin, CD8-Positive T-Lymphocytes, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Tianjin Medical University General Hospital "Excellent Rising Star" Cultivation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Luteolin, a commonly used traditional Chinese medicine, has been utilized for several decades in the treatment of hepatocellular carcinoma (HCC). Previous research has demonstrated its anti‐tumour efficacy, but its underlying mechanism remains unclear. This study aimed to assess the therapeutic effects of luteolin in H22 tumour‐bearing mice. luteolin effectively inhibited the growth of solid tumours in a well‐established mouse model of HCC. High‐throughput sequencing revealed that luteolin treatment could enhance T‐cell activation, cell chemotaxis and cytokine production. In addition, luteolin helped sustain a high ratio of CD8 + T lymphocytes in the spleen, peripheral blood and tumour tissues. The effects of luteolin on the phenotypic and functional changes in tumour‐infiltrating CD8 + T lymphocytes were also investigated. Luteolin restored the cytotoxicity of tumour‐infiltrating CD8 + T lymphocytes in H22 tumour‐bearing mice. The CD8 + T lymphocytes exhibited intensified phenotype activation and increased production of granzyme B, IFN‐γ and TNF‐α in serum. The combined administration of luteolin and the PD‐1 inhibitor enhanced the anti‐tumour effects in H22 tumour‐bearing mice. Luteolin could exert an anti‐tumour immune response by inducing CD8 + T lymphocyte infiltration and enhance the anti‐tumour effects of the PD‐1 inhibitor on H22 tumour‐bearing mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LuteolinCD8-Positive T-LymphocytesCarcinoma, HepatocellularLiver NeoplasmsLymphocytes, Tumor-InfiltratingAnimalsMiceCell Line, TumorLymphocyte ActivationCytokinesMaleGranzymesProgrammed Cell Death 1 ReceptorMice, Inbred C57BL

Stichwörter der Autor:innen

CD8+ T lymphocyte infiltrationPD‐1 inhibitorhepatocellular carcinomahigh‐throughput sequencingluteolin

Substanzen

LuteolinCytokinesGranzymesProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Department of Pharmacy, Tianjin Medical University General Hospital, Tianjin, China.
  • Tianjin Key Laboratory of Digestive Diseases, Department of Gastroenterology and Hepatology, Tianjin Institute of Digestive Diseases, Tianjin Medical University General Hospital, Tianjin, China.

ORCID-Profile: Shijiao Cai, Weilong Zhong

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Tianjin Medical University General Hospital "Excellent Rising Star" Cultivation Project
  • "Unveiling and Hanging" Major Projects of Tianjin Science and Technology Bureau

Zitieren

APA

Cai, S., Gou, Y., Chen, Y., Hou, X., Zhang, J., Bi, C., Gu, P., Yang, M., Zhang, H., Zhong, W., & Yuan, H. (2024). Luteolin exerts anti‐tumour immunity in hepatocellular carcinoma by accelerating CD8 + T lymphocyte infiltration. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18535

Vancouver

Cai S, Gou Y, Chen Y, Hou X, Zhang J, Bi C, et al. Luteolin exerts anti‐tumour immunity in hepatocellular carcinoma by accelerating CD8 + T lymphocyte infiltration. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18535

BibTeX
@article{Cai2024,
  author = {Cai, Shijiao and Gou, Yidan and Chen, Yanyan and Hou, Xiaoran and Zhang, Jing and Bi, Chongwen and Gu, Peng and Yang, Miao and Zhang, Hanxu and Zhong, Weilong and Yuan, Hengjie},
  title = {Luteolin exerts anti‐tumour immunity in hepatocellular carcinoma by accelerating CD8 + T lymphocyte infiltration},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18535}
}
Kostenlos starten →